ISLH 2018

The XXXIst International Symposium on Technological Innovations in Laboratory Hematology

Sebia’s booth number: 118 & 119

Dates: May 10-12, 2018

Location: SQUARE Meeting Centre, Brussels, Belgique

For more infos : ISLH Brussels 2018

Sebia Educational Luncheon Workshop

Thursday, May 10th - From 12:30 to 14:00

Room: Copper Hall

“Sebia capillary electrophoresis: Breakthrough technology deserving your patients with hemoglobin disorders

Fifty years after its creation, Sebia has become a key player in the diagnosis of hemoglobinopathies and thalassemias. The Sebia capillary electrophoresis is accessible to all laboratories and is a unique combination of ease of use, high resolution and high throughput. By attending this workshop, the audience will discover the medical added value offered by this breakthrough technology for hemoglobin disorders diagnosis.

MODERATOR: Cornelis L. HARTEVELD, Leiden University Medical Center, Leiden, The Netherlands

"Haemoglobinopathy Investigation – The case for Capillary Electrophoresis"

  • Jason EYRE
    • Royal Hallamshire Hospital, Sheffield, UK

Mr. Jason EYRE will outline the drivers that led him to use capillary electrophoresis as a first line method for the screening of hemoglobinopathies and thalassemia and what are the advantages of using the CAPILLARYS 3 TERA, the next generation of Sebia multi-parametric capillary electrophoresis instruments. He will also demonstrate how the Sebia Hb A1c assay allows the incidental detection of these hemoglobin disorders during the follow-up or diagnosis of diabetic patients, and gives medical added values to the endocrinologists.

"Newborn Screening of Thalassemia and Hemoglobinopathies – Superiority of Capillary Electrophoresis"

    • Siriraj Hospital, Mahidol University, Bangkok, Thailand

Dr. Vip VIPRAKASIT will demonstrate, with clinical clues, why capillary electrophoresis is a method of choice to screen the population for hemoglobinopathies and thalassemias, and especially the newborns. He will explain why capillary electrophoresis can be easily integrated in NBS strategy of a routine laboratory and how this technique can be helpful for supporting a long-term hemoglobinopathies and thalassemias prevention program, particularly in Thailand.